ELAN Elanco Animal Health Incorporated
ELAN Elanco Animal Health Incorporated
Healthcare · Drug Manufacturers - Specialty & Generic
Desk view
Market read
POC $22.44 · VWAP $23.44 · -3.9% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster
Coverage
1 related campaign
ELAN Price Structure
Loading timeframes…
Peers
Every watchlist ELAN belongs to, members best 30-day change first — ELAN highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@livestock-disease
Reported the quarter ending 2026-06-30: revenue $1.37B, diluted EPS $0.11, net income $54M (SEC filing). Across the print the stock moved -5.5% (close before → first close after).
full note →Against street estimates
How ELAN's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
ELAN research tape
21 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.